Fed. Circ. Upholds Ban On Teva's Generic Evista
A federal appeals court has rejected Teva Pharmaceuticals USA Inc.'s bid to overturn a permanent injunction barring the generic-drug maker from launching a copy of Eli Lilly & Co.'s blockbuster osteoporosis...To view the full article, register now.
Already a subscriber? Click here to view full article